Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia.

MLA

Ma, Sha, et al. “Associations of Granulocyte Colony-Stimulating Factor with Toxicities and Efficacy of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.” Cancer Immunology, Immunotherapy : CII, vol. 73, no. 6, Apr. 2024, p. 104. EBSCOhost, https://doi.org/10.1007/s00262-024-03661-1.

APA

Ma, S., Wang, Y., Qi, K., Lu, W., Qi, Y., Cao, J., Niu, M., Li, D., Sang, W., Yan, Z., Zhu, F., Cheng, H., Li, Z., Zhao, M., & Xu, K. (2024). Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia. Cancer Immunology, Immunotherapy : CII, 73(6), 104. https://doi.org/10.1007/s00262-024-03661-1

Chicago

Ma, Sha, Ying Wang, Kunming Qi, Wenyi Lu, Yuekun Qi, Jiang Cao, Mingshan Niu, et al. 2024. “Associations of Granulocyte Colony-Stimulating Factor with Toxicities and Efficacy of Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.” Cancer Immunology, Immunotherapy : CII 73 (6): 104. doi:10.1007/s00262-024-03661-1.